Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in this important bi-annual critical review of the 'state of the art' in the multidisciplinary care of early-stage br...
Uložené v:
| Vydané v: | Annals of oncology Ročník 32; číslo 10; s. 1216 |
|---|---|
| Hlavní autori: | , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
England
01.10.2021
|
| Predmet: | |
| ISSN: | 1569-8041, 1569-8041 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in this important bi-annual critical review of the 'state of the art' in the multidisciplinary care of early-stage breast cancer. Seventy-four expert panelists (see Appendix 1) from all continents discussed and commented on the previously elaborated consensus questions, as well as many key questions on early breast cancer diagnosis and treatment asked by the audience. The theme of this year's conference was 'Customizing local and systemic therapies.' A well-organized program of pre-recorded symposia, live panel discussions and real-time panel voting results drew a worldwide audience of thousands, reflecting the far-reaching impact of breast cancer on every continent. The interactive technology platform allowed, for the first time, audience members to ask direct questions to panelists, and to weigh in with their own vote on several key panel questions. A hallmark of this meeting was to focus on customized recommendations for treatment of early-stage breast cancer. There is increasing recognition that the care of a breast cancer patient depends on highly individualized clinical features, including the stage at presentation, the biological subset of breast cancer, the genetic factors that may underlie breast cancer risk, the genomic signatures that inform treatment recommendations, the extent of response before surgery in patients who receive neoadjuvant therapy, and patient preferences. This customized approach to treatment requires integration of clinical care between patients and radiology, pathology, genetics, and surgical, medical and radiation oncology providers. It also requires a dynamic response from clinicians as they encounter accumulating clinical information at the time of diagnosis and then serially with each step in the treatment plan and follow-up, reflecting patient experiences and treatment response. |
|---|---|
| AbstractList | The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in this important bi-annual critical review of the 'state of the art' in the multidisciplinary care of early-stage breast cancer. Seventy-four expert panelists (see Appendix 1) from all continents discussed and commented on the previously elaborated consensus questions, as well as many key questions on early breast cancer diagnosis and treatment asked by the audience. The theme of this year's conference was 'Customizing local and systemic therapies.' A well-organized program of pre-recorded symposia, live panel discussions and real-time panel voting results drew a worldwide audience of thousands, reflecting the far-reaching impact of breast cancer on every continent. The interactive technology platform allowed, for the first time, audience members to ask direct questions to panelists, and to weigh in with their own vote on several key panel questions. A hallmark of this meeting was to focus on customized recommendations for treatment of early-stage breast cancer. There is increasing recognition that the care of a breast cancer patient depends on highly individualized clinical features, including the stage at presentation, the biological subset of breast cancer, the genetic factors that may underlie breast cancer risk, the genomic signatures that inform treatment recommendations, the extent of response before surgery in patients who receive neoadjuvant therapy, and patient preferences. This customized approach to treatment requires integration of clinical care between patients and radiology, pathology, genetics, and surgical, medical and radiation oncology providers. It also requires a dynamic response from clinicians as they encounter accumulating clinical information at the time of diagnosis and then serially with each step in the treatment plan and follow-up, reflecting patient experiences and treatment response.The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in this important bi-annual critical review of the 'state of the art' in the multidisciplinary care of early-stage breast cancer. Seventy-four expert panelists (see Appendix 1) from all continents discussed and commented on the previously elaborated consensus questions, as well as many key questions on early breast cancer diagnosis and treatment asked by the audience. The theme of this year's conference was 'Customizing local and systemic therapies.' A well-organized program of pre-recorded symposia, live panel discussions and real-time panel voting results drew a worldwide audience of thousands, reflecting the far-reaching impact of breast cancer on every continent. The interactive technology platform allowed, for the first time, audience members to ask direct questions to panelists, and to weigh in with their own vote on several key panel questions. A hallmark of this meeting was to focus on customized recommendations for treatment of early-stage breast cancer. There is increasing recognition that the care of a breast cancer patient depends on highly individualized clinical features, including the stage at presentation, the biological subset of breast cancer, the genetic factors that may underlie breast cancer risk, the genomic signatures that inform treatment recommendations, the extent of response before surgery in patients who receive neoadjuvant therapy, and patient preferences. This customized approach to treatment requires integration of clinical care between patients and radiology, pathology, genetics, and surgical, medical and radiation oncology providers. It also requires a dynamic response from clinicians as they encounter accumulating clinical information at the time of diagnosis and then serially with each step in the treatment plan and follow-up, reflecting patient experiences and treatment response. The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in this important bi-annual critical review of the 'state of the art' in the multidisciplinary care of early-stage breast cancer. Seventy-four expert panelists (see Appendix 1) from all continents discussed and commented on the previously elaborated consensus questions, as well as many key questions on early breast cancer diagnosis and treatment asked by the audience. The theme of this year's conference was 'Customizing local and systemic therapies.' A well-organized program of pre-recorded symposia, live panel discussions and real-time panel voting results drew a worldwide audience of thousands, reflecting the far-reaching impact of breast cancer on every continent. The interactive technology platform allowed, for the first time, audience members to ask direct questions to panelists, and to weigh in with their own vote on several key panel questions. A hallmark of this meeting was to focus on customized recommendations for treatment of early-stage breast cancer. There is increasing recognition that the care of a breast cancer patient depends on highly individualized clinical features, including the stage at presentation, the biological subset of breast cancer, the genetic factors that may underlie breast cancer risk, the genomic signatures that inform treatment recommendations, the extent of response before surgery in patients who receive neoadjuvant therapy, and patient preferences. This customized approach to treatment requires integration of clinical care between patients and radiology, pathology, genetics, and surgical, medical and radiation oncology providers. It also requires a dynamic response from clinicians as they encounter accumulating clinical information at the time of diagnosis and then serially with each step in the treatment plan and follow-up, reflecting patient experiences and treatment response. |
| Author | Weber, W P Burstein, H J Curigliano, G Gnant, M Thürlimann, B Poortmans, P Senn, H J Regan, M M Winer, E P |
| Author_xml | – sequence: 1 givenname: H J surname: Burstein fullname: Burstein, H J email: hburstein@partners.org organization: Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. Electronic address: hburstein@partners.org – sequence: 2 givenname: G surname: Curigliano fullname: Curigliano, G email: giuseppe.curigliano@ieo.it organization: European Institute of Oncology, University of Milan, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it – sequence: 3 givenname: B surname: Thürlimann fullname: Thürlimann, B organization: Cantonal Hospital, St. Gallen, Switzerland – sequence: 4 givenname: W P surname: Weber fullname: Weber, W P organization: University of Basel, Basel, Switzerland – sequence: 5 givenname: P surname: Poortmans fullname: Poortmans, P organization: University of Antwerp, Antwerp, Belgium – sequence: 6 givenname: M M surname: Regan fullname: Regan, M M organization: Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA – sequence: 7 givenname: H J surname: Senn fullname: Senn, H J organization: St. Gallen Oncology Conferences (Foundation SONK), St. Gallen, Switzerland – sequence: 8 givenname: E P surname: Winer fullname: Winer, E P organization: Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA – sequence: 9 givenname: M surname: Gnant fullname: Gnant, M organization: Medical University of Vienna, Vienna, Austria |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34242744$$D View this record in MEDLINE/PubMed |
| BookMark | eNpt0M1KxDAQwPEgit9vIJKjl61JNum23qToKgge1PMyTaZuljRZkxRZn8jHtOIKHjxlGP78YHJEdn3wSMgZZwVnvLxcFeDHlS4EE7xgZcHEdIccclXWk4pJvvtnPiBHKa0YY2Ut6n1yMJVCipmUh-SzGVIOvf2w_pW6oMFR8IamTcrYW03zEiOsLSbahUjfQ4-evtu8pAjRbWgbEVKmGrzGePVd06dc0Dk4N4b3PmP0kG3wo9sEn9CnIdH5YA0667dqHpE8wpmG7j-Xfl94QvY6cAlPt-8xebm9eW7uJg-P8_vm-mGiFeN5YmDaSmHUdFaZuhJcd6Ckqk1dozGcaah4K8uu02wmjVKg6lJXoHmLrVAzrsQxufhx1zG8DZjyordJo3PgMQxpIZRiouSs4mN6vk2HtkezWEfbQ9wsfn9XfAHyYYL0 |
| CitedBy_id | crossref_primary_10_3233_CH_231936 crossref_primary_10_1016_j_annonc_2022_03_273 crossref_primary_10_1007_s12282_025_01712_8 crossref_primary_10_1016_j_jrras_2023_100692 crossref_primary_10_1097_RLI_0000000000001051 crossref_primary_10_1016_j_ijbiomac_2024_139443 crossref_primary_10_1016_j_jrras_2024_100971 crossref_primary_10_1016_j_tranon_2022_101615 crossref_primary_10_1080_00325481_2024_2370235 crossref_primary_10_1016_j_ejso_2023_04_017 crossref_primary_10_1016_j_breast_2025_104436 crossref_primary_10_3233_THC_240695 crossref_primary_10_3390_ijerph20021617 crossref_primary_10_1371_journal_pone_0274804 crossref_primary_10_3390_cancers13194883 crossref_primary_10_1007_s10549_023_07094_9 crossref_primary_10_1007_s10549_023_07071_2 crossref_primary_10_1016_j_tranon_2025_102410 crossref_primary_10_1016_S1470_2045_24_00456_X crossref_primary_10_2147_BCTT_S416998 crossref_primary_10_3390_biom12070952 crossref_primary_10_1093_jnci_djae115 crossref_primary_10_3233_CBM_230576 crossref_primary_10_1002_cam4_5022 crossref_primary_10_1016_j_bbi_2023_02_004 crossref_primary_10_1016_j_mri_2025_110343 crossref_primary_10_1007_s10549_022_06724_y crossref_primary_10_1038_s41598_024_75154_1 crossref_primary_10_1016_j_eclinm_2024_102928 crossref_primary_10_3390_cancers15051385 crossref_primary_10_1186_s12885_024_13091_y crossref_primary_10_1177_03008916231216830 crossref_primary_10_3389_fonc_2024_1505934 crossref_primary_10_1016_j_ejso_2023_03_226 crossref_primary_10_1093_jnci_djae268 crossref_primary_10_3389_fonc_2022_989650 crossref_primary_10_1016_j_ejca_2023_113358 crossref_primary_10_1177_11782234231192780 crossref_primary_10_3390_cancers17183089 crossref_primary_10_1016_j_breast_2023_07_009 crossref_primary_10_1016_j_breast_2025_104415 crossref_primary_10_1016_j_radonc_2025_111054 crossref_primary_10_1016_j_critrevonc_2022_103774 crossref_primary_10_3389_fimmu_2024_1424259 crossref_primary_10_1016_j_critrevonc_2023_104089 crossref_primary_10_2196_50931 crossref_primary_10_3389_fonc_2025_1542643 crossref_primary_10_2147_IJN_S477652 crossref_primary_10_31083_j_fbl2902090 crossref_primary_10_1016_j_breast_2025_104423 crossref_primary_10_1007_s10549_025_07610_z crossref_primary_10_1111_ans_19404 crossref_primary_10_1016_j_ctrv_2024_102770 crossref_primary_10_3892_mmr_2023_13134 crossref_primary_10_1007_s10549_022_06767_1 crossref_primary_10_1038_s41417_025_00943_3 crossref_primary_10_3389_fonc_2023_1041111 crossref_primary_10_1136_bmjopen_2024_087700 crossref_primary_10_1016_j_ejso_2022_03_002 crossref_primary_10_1016_j_breast_2022_12_010 crossref_primary_10_1016_j_heliyon_2025_e42024 crossref_primary_10_3389_fsurg_2022_858349 crossref_primary_10_1002_cam4_5693 crossref_primary_10_1200_GO_23_00010 crossref_primary_10_20960_nh_05139 crossref_primary_10_1016_j_ejrad_2023_111270 crossref_primary_10_3390_jcm13071873 crossref_primary_10_1007_s00432_022_04046_6 crossref_primary_10_3389_fendo_2022_1015388 crossref_primary_10_3390_cancers17050763 crossref_primary_10_3390_cancers15225430 crossref_primary_10_3390_diagnostics12071740 crossref_primary_10_7554_eLife_101724_3 crossref_primary_10_1186_s12885_024_12222_9 crossref_primary_10_1245_s10434_024_15282_0 crossref_primary_10_1080_03601234_2024_2357465 crossref_primary_10_1042_BSR20220645 crossref_primary_10_3390_biomedicines11082300 crossref_primary_10_1097_CJI_0000000000000517 crossref_primary_10_1007_s00428_024_03856_y crossref_primary_10_1080_07853890_2025_2559132 crossref_primary_10_1200_JCO_23_02170 crossref_primary_10_1245_s10434_022_12310_9 crossref_primary_10_1016_j_ejca_2022_09_024 crossref_primary_10_1007_s10549_024_07274_1 crossref_primary_10_3389_fonc_2023_1256360 crossref_primary_10_1007_s10552_025_02004_4 crossref_primary_10_1007_s10549_022_06559_7 crossref_primary_10_1007_s10549_023_07107_7 crossref_primary_10_1016_j_jss_2024_04_057 crossref_primary_10_3322_caac_70016 crossref_primary_10_1007_s10549_025_07778_4 crossref_primary_10_3390_healthcare11091324 crossref_primary_10_1016_j_acra_2024_06_004 crossref_primary_10_3892_ol_2025_14982 crossref_primary_10_1590_0034_7167_2022_0428pt crossref_primary_10_1016_j_ijrobp_2024_06_016 crossref_primary_10_1186_s13058_022_01586_0 crossref_primary_10_3389_pore_2022_1610377 crossref_primary_10_1016_j_prro_2024_05_012 crossref_primary_10_3389_pore_2022_1610373 crossref_primary_10_3389_fonc_2024_1388869 crossref_primary_10_1016_j_tranon_2025_102330 crossref_primary_10_3389_fonc_2023_1138049 crossref_primary_10_1016_j_yao_2022_01_004 crossref_primary_10_1016_j_breast_2022_12_004 crossref_primary_10_1016_j_intimp_2024_112411 crossref_primary_10_1007_s12609_024_00568_9 crossref_primary_10_1021_acsnano_5c09287 crossref_primary_10_1088_1748_605X_ad3f61 crossref_primary_10_2147_OTT_S484293 crossref_primary_10_1007_s00432_024_05810_6 crossref_primary_10_1038_s41598_024_83362_y crossref_primary_10_3389_fonc_2023_1270407 crossref_primary_10_1007_s10549_022_06535_1 crossref_primary_10_1016_j_ejso_2025_110356 crossref_primary_10_1097_JS9_0000000000001586 crossref_primary_10_1016_j_critrevonc_2022_103900 crossref_primary_10_1016_j_ctrv_2025_102887 crossref_primary_10_1016_j_ejso_2024_108554 crossref_primary_10_1590_0034_7167_2022_0428 crossref_primary_10_18027_2224_5057_2024_003 crossref_primary_10_1080_03007995_2024_2332436 crossref_primary_10_1038_s41598_024_64696_z crossref_primary_10_1007_s10549_024_07318_6 crossref_primary_10_1016_j_critrevonc_2023_104035 crossref_primary_10_56969_oc_v30i1_197 crossref_primary_10_3389_fphar_2022_821779 crossref_primary_10_1097_PAS_0000000000002252 crossref_primary_10_1016_j_nano_2023_102707 crossref_primary_10_3389_fonc_2023_1269971 crossref_primary_10_3390_cancers16010188 crossref_primary_10_1016_S1470_2045_23_00460_6 crossref_primary_10_1038_s41598_023_45438_z crossref_primary_10_2147_PPA_S443217 crossref_primary_10_3389_fonc_2021_779140 crossref_primary_10_1016_S1470_2045_23_00615_0 crossref_primary_10_1007_s10549_024_07470_z crossref_primary_10_1016_j_critrevonc_2023_104148 crossref_primary_10_1039_D5FO01116G crossref_primary_10_3390_cancers14225609 crossref_primary_10_1016_j_ejphar_2025_177635 crossref_primary_10_1038_s41523_022_00434_w crossref_primary_10_1016_j_breast_2023_05_005 crossref_primary_10_3390_curroncol32060307 crossref_primary_10_1080_17568919_2025_2542720 crossref_primary_10_1245_s10434_024_15790_z crossref_primary_10_1371_journal_pone_0293830 crossref_primary_10_1177_17588359221118053 crossref_primary_10_3389_fphar_2024_1438288 crossref_primary_10_1002_cam4_5319 crossref_primary_10_1159_000531137 crossref_primary_10_1007_s10495_024_02032_6 crossref_primary_10_1016_j_critrevonc_2024_104537 crossref_primary_10_1002_cai2_70016 crossref_primary_10_1007_s11764_024_01699_9 crossref_primary_10_1158_2326_6066_CIR_23_0076 crossref_primary_10_1016_S1470_2045_23_00051_7 crossref_primary_10_1016_j_clbc_2025_07_010 crossref_primary_10_1016_j_clbc_2025_07_011 crossref_primary_10_1016_j_modpat_2025_100850 crossref_primary_10_3389_fonc_2022_799232 crossref_primary_10_1016_j_hpr_2021_300574 crossref_primary_10_3233_BD_210071 crossref_primary_10_3389_fonc_2022_779786 crossref_primary_10_1016_S1470_2045_24_00491_1 crossref_primary_10_3389_fimmu_2025_1540018 crossref_primary_10_1016_j_bcp_2024_116047 crossref_primary_10_3389_fonc_2023_1151460 crossref_primary_10_1371_journal_pone_0289365 crossref_primary_10_3389_fonc_2025_1469684 crossref_primary_10_1007_s10549_023_07097_6 crossref_primary_10_1016_j_soncn_2024_151609 crossref_primary_10_1245_s10434_025_17110_5 crossref_primary_10_3389_fonc_2025_1563969 crossref_primary_10_1007_s10549_022_06677_2 crossref_primary_10_1016_j_critrevonc_2024_104421 crossref_primary_10_1016_j_cson_2024_100044 crossref_primary_10_3390_ijms25073911 crossref_primary_10_1016_j_breast_2024_103670 crossref_primary_10_1016_j_breast_2024_103671 crossref_primary_10_1016_j_canrad_2023_11_001 crossref_primary_10_3390_cancers15174336 crossref_primary_10_1245_s10434_022_11913_6 crossref_primary_10_1002_advs_202308255 crossref_primary_10_1038_s41392_025_02298_5 crossref_primary_10_1016_j_clbc_2024_10_005 crossref_primary_10_3389_fbioe_2021_808933 crossref_primary_10_1007_s10549_022_06787_x crossref_primary_10_1245_s10434_023_13231_x crossref_primary_10_3389_fonc_2023_1169010 crossref_primary_10_1016_j_ejso_2022_05_012 crossref_primary_10_3389_fonc_2023_1337315 crossref_primary_10_1097_HM9_0000000000000057 crossref_primary_10_12677_MD_2023_133052 crossref_primary_10_3389_fmed_2025_1593143 crossref_primary_10_1093_oncolo_oyae191 crossref_primary_10_3390_genes16010082 crossref_primary_10_1007_s41669_024_00519_1 crossref_primary_10_1038_s41523_023_00589_0 crossref_primary_10_1186_s40001_022_00784_y crossref_primary_10_1097_MD_0000000000036788 crossref_primary_10_1007_s10753_023_01830_5 crossref_primary_10_3389_fonc_2023_1081885 crossref_primary_10_3390_biomedicines11113037 crossref_primary_10_1016_j_radonc_2025_110710 crossref_primary_10_3389_fonc_2023_1287253 crossref_primary_10_1016_j_prp_2023_154728 crossref_primary_10_1186_s12938_024_01274_4 crossref_primary_10_1016_S0140_6736_23_00285_4 crossref_primary_10_1111_rda_14408 crossref_primary_10_1039_D3RA01006F crossref_primary_10_1186_s40792_023_01626_7 crossref_primary_10_1097_CCO_0000000000000906 crossref_primary_10_1055_a_2238_3199 crossref_primary_10_5772_dmht_08 crossref_primary_10_3390_cancers15153847 crossref_primary_10_3390_molecules30071571 crossref_primary_10_1002_cnr2_1974 crossref_primary_10_1007_s12094_024_03714_y crossref_primary_10_1186_s12893_023_02181_6 crossref_primary_10_1002_cncr_35389 crossref_primary_10_3390_cancers14235855 crossref_primary_10_1007_s00761_023_01422_w crossref_primary_10_7759_cureus_51617 crossref_primary_10_1038_s41746_025_01509_1 crossref_primary_10_1016_j_ultrasmedbio_2025_06_028 crossref_primary_10_1038_s41598_024_61807_8 crossref_primary_10_1186_s13058_023_01751_z crossref_primary_10_1097_PPO_0000000000000559 crossref_primary_10_1186_s13058_024_01781_1 crossref_primary_10_3390_su16198396 crossref_primary_10_1186_s42047_022_00121_x crossref_primary_10_1016_j_breast_2024_103753 crossref_primary_10_3389_fonc_2022_762906 crossref_primary_10_1111_his_15193 crossref_primary_10_2196_69855 crossref_primary_10_1007_s10549_023_07186_6 crossref_primary_10_3390_cancers15010148 crossref_primary_10_3390_jpm13020249 crossref_primary_10_1016_j_annonc_2023_08_017 crossref_primary_10_1016_j_ejso_2025_110079 crossref_primary_10_1016_j_prro_2024_07_003 crossref_primary_10_1016_j_ahj_2023_10_007 crossref_primary_10_1016_j_clbc_2023_01_006 crossref_primary_10_3390_cancers16213638 crossref_primary_10_3389_fonc_2023_1116631 crossref_primary_10_1016_j_clbc_2025_05_022 crossref_primary_10_1007_s10549_022_06588_2 crossref_primary_10_1186_s12935_024_03237_0 crossref_primary_10_1016_j_radonc_2021_08_013 crossref_primary_10_1007_s10549_023_07199_1 crossref_primary_10_1016_S1470_2045_22_00195_4 crossref_primary_10_1007_s10549_023_07033_8 crossref_primary_10_3390_cancers15113007 crossref_primary_10_3390_cancers15061719 crossref_primary_10_1016_j_annonc_2021_12_004 crossref_primary_10_1245_s10434_024_15354_1 crossref_primary_10_1016_j_breast_2022_01_006 crossref_primary_10_3390_diagnostics13122064 crossref_primary_10_1007_s00520_024_08485_4 crossref_primary_10_3390_jcm13226739 crossref_primary_10_1016_j_jrras_2025_101328 crossref_primary_10_1158_1078_0432_CCR_23_1248 crossref_primary_10_1007_s10549_023_07021_y crossref_primary_10_1245_s10434_023_14404_4 crossref_primary_10_3390_ncrna10020016 crossref_primary_10_3892_ol_2024_14331 crossref_primary_10_1038_s41598_022_11411_5 crossref_primary_10_1111_his_15140 crossref_primary_10_1245_s10434_022_12197_6 crossref_primary_10_1007_s11033_024_09665_5 crossref_primary_10_1007_s10549_024_07303_z crossref_primary_10_1016_S1470_2045_21_00756_7 crossref_primary_10_3390_diagnostics13091582 crossref_primary_10_1007_s12032_022_01829_2 crossref_primary_10_1016_j_clbc_2023_08_002 crossref_primary_10_1080_1354750X_2024_2358302 crossref_primary_10_1002_mp_17813 crossref_primary_10_1007_s12282_023_01518_6 crossref_primary_10_1016_j_mednuc_2025_07_002 crossref_primary_10_1007_s12282_024_01621_2 crossref_primary_10_1007_s10549_022_06708_y crossref_primary_10_3390_biomedicines11082286 crossref_primary_10_1007_s12672_025_03118_6 crossref_primary_10_1016_j_ejrad_2022_110232 crossref_primary_10_1016_j_pathol_2023_10_014 crossref_primary_10_1016_j_ctrv_2021_102323 crossref_primary_10_1016_j_clbc_2025_04_016 crossref_primary_10_1016_j_clbc_2025_04_019 crossref_primary_10_1007_s12282_024_01626_x crossref_primary_10_1016_j_prp_2023_154349 crossref_primary_10_3390_biomedicines13061364 crossref_primary_10_24060_2076_3093_2022_12_3_199_204 crossref_primary_10_1016_j_clbc_2024_12_018 crossref_primary_10_1016_j_clbc_2025_04_011 crossref_primary_10_1186_s12957_024_03366_w crossref_primary_10_1007_s12282_023_01528_4 crossref_primary_10_1080_07357907_2023_2238312 crossref_primary_10_1002_jso_26847 crossref_primary_10_1097_CCO_0000000000000893 crossref_primary_10_1016_j_breast_2024_103822 crossref_primary_10_1038_s41392_023_01337_3 crossref_primary_10_1245_s10434_025_16985_8 crossref_primary_10_3390_diagnostics15111300 crossref_primary_10_1016_j_breast_2023_04_006 crossref_primary_10_1016_j_acra_2025_04_010 crossref_primary_10_1007_s10549_022_06839_2 crossref_primary_10_1007_s11523_025_01158_0 crossref_primary_10_1016_j_critrevonc_2023_104104 crossref_primary_10_5858_arpa_2022_0370_OA crossref_primary_10_1002_cac2_12358 crossref_primary_10_1038_s41523_025_00744_9 crossref_primary_10_1007_s10552_024_01857_5 crossref_primary_10_3390_ph18040539 crossref_primary_10_1080_14737140_2023_2248387 crossref_primary_10_1016_j_anndiagpath_2024_152396 crossref_primary_10_1007_s12094_023_03347_7 crossref_primary_10_1016_j_brachy_2023_01_002 crossref_primary_10_1186_s12957_022_02790_0 crossref_primary_10_1016_j_radonc_2022_09_007 crossref_primary_10_1038_s41419_024_07037_2 crossref_primary_10_1016_j_hoc_2022_08_004 crossref_primary_10_1164_rccm_202311_2086SO crossref_primary_10_1007_s00432_025_06113_0 crossref_primary_10_1097_CCO_0000000000000986 crossref_primary_10_1002_bab_2792 crossref_primary_10_1097_CCO_0000000000000872 crossref_primary_10_3390_genes14020296 crossref_primary_10_1016_j_semradonc_2022_01_004 crossref_primary_10_1186_s12893_025_03118_x crossref_primary_10_1016_j_hoc_2022_08_011 crossref_primary_10_1186_s12957_025_03801_6 crossref_primary_10_1002_jso_27717 crossref_primary_10_1093_bjsopen_zrae100 crossref_primary_10_3389_fcvm_2023_1078135 crossref_primary_10_1111_ajco_13923 crossref_primary_10_3390_biomedicines10102656 crossref_primary_10_3390_ijms242015332 crossref_primary_10_1016_j_hoc_2022_08_018 crossref_primary_10_3389_fpsyg_2022_931679 crossref_primary_10_1016_j_hoc_2022_08_014 crossref_primary_10_1186_s13058_023_01672_x crossref_primary_10_1093_jncics_pkaf049 crossref_primary_10_1177_15330338221137216 crossref_primary_10_3389_fonc_2025_1544058 crossref_primary_10_1007_s00210_023_02885_9 crossref_primary_10_1016_j_asjsur_2024_12_023 crossref_primary_10_3389_fonc_2022_866889 crossref_primary_10_1002_jmri_28771 crossref_primary_10_1016_j_gofs_2023_12_010 crossref_primary_10_1200_JCO_24_01052 crossref_primary_10_1007_s10278_024_01229_0 crossref_primary_10_1016_j_csbj_2024_02_016 crossref_primary_10_1158_1541_7786_MCR_25_0124 crossref_primary_10_62347_GWCJ5941 crossref_primary_10_1245_s10434_022_12640_8 crossref_primary_10_1038_s41392_024_02108_4 crossref_primary_10_3390_diagnostics12040870 crossref_primary_10_1016_j_clbc_2024_01_001 crossref_primary_10_1016_j_ejca_2022_08_027 crossref_primary_10_1155_2024_8851703 crossref_primary_10_3390_cancers14215467 crossref_primary_10_1155_2021_5529106 crossref_primary_10_1016_j_pathol_2022_05_003 crossref_primary_10_3389_fonc_2024_1295772 crossref_primary_10_1016_j_jddst_2023_104433 crossref_primary_10_1371_journal_pone_0330571 crossref_primary_10_2147_CMAR_S345102 crossref_primary_10_3390_genes15111458 crossref_primary_10_1016_j_ijrobp_2023_05_040 crossref_primary_10_1097_CEJ_0000000000000821 crossref_primary_10_1007_s00428_023_03566_x crossref_primary_10_1007_s12668_024_01639_y crossref_primary_10_3389_fimmu_2023_1281056 crossref_primary_10_1186_s12885_022_10163_9 crossref_primary_10_3390_cancers15225353 crossref_primary_10_1016_j_clbc_2024_08_003 crossref_primary_10_1136_bmjopen_2024_084488 crossref_primary_10_1007_s00129_022_04934_5 crossref_primary_10_1016_j_suronc_2024_102062 crossref_primary_10_1186_s40364_024_00654_1 crossref_primary_10_1002_prca_202300061 crossref_primary_10_1016_j_jddst_2022_104050 crossref_primary_10_3390_pharmaceutics14020292 crossref_primary_10_1038_s41598_023_32227_x crossref_primary_10_1007_s12325_023_02566_2 crossref_primary_10_1016_j_breast_2022_07_008 crossref_primary_10_1016_j_ejca_2023_113401 crossref_primary_10_1007_s12032_024_02477_4 crossref_primary_10_7554_eLife_101724 crossref_primary_10_1038_s41598_023_38760_z crossref_primary_10_21518_ms2025_118 crossref_primary_10_1080_13543784_2022_2095260 crossref_primary_10_1177_17588359221138657 crossref_primary_10_3390_cancers14030635 crossref_primary_10_1016_j_ijbiomac_2023_124832 crossref_primary_10_1038_s41598_025_92137_y crossref_primary_10_1038_s41523_023_00560_z crossref_primary_10_7759_cureus_76392 crossref_primary_10_3390_mps5050078 crossref_primary_10_1016_j_critrevonc_2023_103952 crossref_primary_10_1038_s41392_025_02138_6 crossref_primary_10_1080_14796694_2025_2526268 crossref_primary_10_1001_jamanetworkopen_2023_21388 crossref_primary_10_1038_s41598_024_67291_4 crossref_primary_10_1148_radiol_221777 crossref_primary_10_1158_1078_0432_CCR_24_3402 crossref_primary_10_3390_cancers15082251 crossref_primary_10_1016_j_acra_2022_09_022 crossref_primary_10_1007_s12094_024_03459_8 crossref_primary_10_1186_s12880_025_01698_x crossref_primary_10_5306_wjco_v14_i9_335 crossref_primary_10_3390_jcm14020484 crossref_primary_10_1002_jmri_29456 crossref_primary_10_3389_fendo_2024_1254213 crossref_primary_10_2147_IJGM_S407725 crossref_primary_10_1016_j_adcanc_2022_100086 crossref_primary_10_1200_EDBK_438776 crossref_primary_10_51643_22562915_769 crossref_primary_10_1002_ddr_22264 crossref_primary_10_3390_diagnostics14010097 crossref_primary_10_12998_wjcc_v12_i20_4074 crossref_primary_10_3390_cancers14133245 crossref_primary_10_1002_cncr_34750 crossref_primary_10_3389_fonc_2024_1382701 crossref_primary_10_3390_diagnostics13142420 crossref_primary_10_3390_cancers16132332 crossref_primary_10_1007_s10528_025_11129_9 crossref_primary_10_1007_s12282_024_01570_w crossref_primary_10_1158_1078_0432_CCR_23_1836 crossref_primary_10_1097_CEJ_0000000000000741 crossref_primary_10_1016_j_ejca_2022_07_036 crossref_primary_10_1016_j_phymed_2025_157097 crossref_primary_10_2147_IJGM_S521769 crossref_primary_10_1177_10732748241261553 crossref_primary_10_1016_j_aspetd_2025_100005 crossref_primary_10_3390_jcm13010217 crossref_primary_10_1080_09553002_2023_2258190 crossref_primary_10_3390_ijms24021799 crossref_primary_10_1016_S0140_6736_23_00094_6 crossref_primary_10_1007_s00726_024_03393_7 crossref_primary_10_1016_j_ctrv_2023_102669 crossref_primary_10_1016_j_clbc_2023_07_004 crossref_primary_10_1007_s12282_024_01628_9 crossref_primary_10_1016_j_clbc_2023_07_006 crossref_primary_10_1038_s41598_024_51723_2 crossref_primary_10_25259_IJRSMS_40_2025 crossref_primary_10_3390_cancers16030539 crossref_primary_10_1007_s00520_022_07502_8 crossref_primary_10_1007_s10549_023_06999_9 crossref_primary_10_3389_fonc_2022_1108695 crossref_primary_10_1186_s12885_022_10250_x crossref_primary_10_3389_fsurg_2024_1410127 crossref_primary_10_1007_s12011_023_03810_0 crossref_primary_10_1080_14796694_2025_2459548 crossref_primary_10_1186_s12885_025_14556_4 crossref_primary_10_1186_s12905_024_03231_8 crossref_primary_10_3389_fimmu_2024_1483595 crossref_primary_10_1186_s12957_022_02779_9 crossref_primary_10_1158_1078_0432_CCR_24_3435 crossref_primary_10_2147_BCTT_S380754 crossref_primary_10_1002_bab_2719 crossref_primary_10_1038_s41416_022_02111_y crossref_primary_10_1016_j_bbcan_2023_188991 crossref_primary_10_3390_cancers15030767 crossref_primary_10_1038_s41598_023_32579_4 crossref_primary_10_3390_molecules28145349 crossref_primary_10_3390_cancers14194815 crossref_primary_10_3389_fonc_2021_741120 crossref_primary_10_12968_hmed_2024_0809 crossref_primary_10_3390_biomedicines11030968 crossref_primary_10_1016_j_ctrv_2023_102556 crossref_primary_10_61706_MECOJ160157 crossref_primary_10_3390_cancers15072130 crossref_primary_10_2147_BCTT_S451617 crossref_primary_10_3389_fonc_2023_1207948 crossref_primary_10_1016_j_breast_2025_104465 crossref_primary_10_3390_cancers16061121 crossref_primary_10_1016_j_phymed_2025_157074 crossref_primary_10_1007_s12672_022_00506_0 crossref_primary_10_1016_j_ctrv_2022_102375 crossref_primary_10_2147_PPA_S432821 crossref_primary_10_3390_ijms242115817 |
| ContentType | Journal Article |
| Contributor | Francis, Prudence Curigliano, Giuseppe Toi, Masakazu Spanic, Tanja Vaz Luis, Inez Barrios, Carlos Harbeck, Nadia Sedlmayer, Felix Ejlertsen, Bent Lee, Eun Sook Colleoni, Marco Tjulandin, Sergei Trudeau, Maureen Dubsky, Peter Semiglazov, Vladimir Delaloge, Suzette Thürlimann, Beat Viale, Giuseppe Bergh, Jonas Bretel Morales, Denisse Gradishar, William Morrow, Monica Johnston, Steven Rugo, Hope Tesarova, Petra Chua, Boon Rutgers, Emiel Ciruelos, Eva Partridge, Ann Gnant, Michael Winer, Eric P Jiang, Zefei Aebi, Stephan Carey, Lisa Shao, Zhiming Cameron, David Weber, Walter P Gamal El Din Mohamed Mahmoud, Hebatallah Prat, Aleix Huober, Jens Regan, Meredith Denkert, Carsten Senn, Hans-Joerg Garber, Judy Huang, Chiun-Sheng Burstein, Harold Ilbawi, Andre Brucker, Sara Galimberti, Viviana Gulluoglu, Bahadir Watanabe, Toru André, Fabrice Cardoso, Fatima Loibl, Sibylle Piccart, Martine Xu, Binghe Poortmans, Philip Turner, Nicholas Bonnefoi, Herve Fitzal, Florian Rubio, Isabella |
| Contributor_xml | – sequence: 1 givenname: Stephan surname: Aebi fullname: Aebi, Stephan – sequence: 2 givenname: Fabrice surname: André fullname: André, Fabrice – sequence: 3 givenname: Carlos surname: Barrios fullname: Barrios, Carlos – sequence: 4 givenname: Jonas surname: Bergh fullname: Bergh, Jonas – sequence: 5 givenname: Herve surname: Bonnefoi fullname: Bonnefoi, Herve – sequence: 6 givenname: Denisse surname: Bretel Morales fullname: Bretel Morales, Denisse – sequence: 7 givenname: Sara surname: Brucker fullname: Brucker, Sara – sequence: 8 givenname: Harold surname: Burstein fullname: Burstein, Harold – sequence: 9 givenname: David surname: Cameron fullname: Cameron, David – sequence: 10 givenname: Fatima surname: Cardoso fullname: Cardoso, Fatima – sequence: 11 givenname: Lisa surname: Carey fullname: Carey, Lisa – sequence: 12 givenname: Boon surname: Chua fullname: Chua, Boon – sequence: 13 givenname: Eva surname: Ciruelos fullname: Ciruelos, Eva – sequence: 14 givenname: Marco surname: Colleoni fullname: Colleoni, Marco – sequence: 15 givenname: Giuseppe surname: Curigliano fullname: Curigliano, Giuseppe – sequence: 16 givenname: Suzette surname: Delaloge fullname: Delaloge, Suzette – sequence: 17 givenname: Carsten surname: Denkert fullname: Denkert, Carsten – sequence: 18 givenname: Peter surname: Dubsky fullname: Dubsky, Peter – sequence: 19 givenname: Bent surname: Ejlertsen fullname: Ejlertsen, Bent – sequence: 20 givenname: Florian surname: Fitzal fullname: Fitzal, Florian – sequence: 21 givenname: Prudence surname: Francis fullname: Francis, Prudence – sequence: 22 givenname: Viviana surname: Galimberti fullname: Galimberti, Viviana – sequence: 23 givenname: Hebatallah surname: Gamal El Din Mohamed Mahmoud fullname: Gamal El Din Mohamed Mahmoud, Hebatallah – sequence: 24 givenname: Judy surname: Garber fullname: Garber, Judy – sequence: 25 givenname: Michael surname: Gnant fullname: Gnant, Michael – sequence: 26 givenname: William surname: Gradishar fullname: Gradishar, William – sequence: 27 givenname: Bahadir surname: Gulluoglu fullname: Gulluoglu, Bahadir – sequence: 28 givenname: Nadia surname: Harbeck fullname: Harbeck, Nadia – sequence: 29 givenname: Chiun-Sheng surname: Huang fullname: Huang, Chiun-Sheng – sequence: 30 givenname: Jens surname: Huober fullname: Huober, Jens – sequence: 31 givenname: Andre surname: Ilbawi fullname: Ilbawi, Andre – sequence: 32 givenname: Zefei surname: Jiang fullname: Jiang, Zefei – sequence: 33 givenname: Steven surname: Johnston fullname: Johnston, Steven – sequence: 34 givenname: Eun Sook surname: Lee fullname: Lee, Eun Sook – sequence: 35 givenname: Sibylle surname: Loibl fullname: Loibl, Sibylle – sequence: 36 givenname: Monica surname: Morrow fullname: Morrow, Monica – sequence: 37 givenname: Ann surname: Partridge fullname: Partridge, Ann – sequence: 38 givenname: Martine surname: Piccart fullname: Piccart, Martine – sequence: 39 givenname: Philip surname: Poortmans fullname: Poortmans, Philip – sequence: 40 givenname: Aleix surname: Prat fullname: Prat, Aleix – sequence: 41 givenname: Meredith surname: Regan fullname: Regan, Meredith – sequence: 42 givenname: Isabella surname: Rubio fullname: Rubio, Isabella – sequence: 43 givenname: Hope surname: Rugo fullname: Rugo, Hope – sequence: 44 givenname: Emiel surname: Rutgers fullname: Rutgers, Emiel – sequence: 45 givenname: Felix surname: Sedlmayer fullname: Sedlmayer, Felix – sequence: 46 givenname: Vladimir surname: Semiglazov fullname: Semiglazov, Vladimir – sequence: 47 givenname: Hans-Joerg surname: Senn fullname: Senn, Hans-Joerg – sequence: 48 givenname: Zhiming surname: Shao fullname: Shao, Zhiming – sequence: 49 givenname: Tanja surname: Spanic fullname: Spanic, Tanja – sequence: 50 givenname: Petra surname: Tesarova fullname: Tesarova, Petra – sequence: 51 givenname: Beat surname: Thürlimann fullname: Thürlimann, Beat – sequence: 52 givenname: Sergei surname: Tjulandin fullname: Tjulandin, Sergei – sequence: 53 givenname: Masakazu surname: Toi fullname: Toi, Masakazu – sequence: 54 givenname: Maureen surname: Trudeau fullname: Trudeau, Maureen – sequence: 55 givenname: Nicholas surname: Turner fullname: Turner, Nicholas – sequence: 56 givenname: Inez surname: Vaz Luis fullname: Vaz Luis, Inez – sequence: 57 givenname: Giuseppe surname: Viale fullname: Viale, Giuseppe – sequence: 58 givenname: Toru surname: Watanabe fullname: Watanabe, Toru – sequence: 59 givenname: Walter P surname: Weber fullname: Weber, Walter P – sequence: 60 givenname: Eric P surname: Winer fullname: Winer, Eric P – sequence: 61 givenname: Binghe surname: Xu fullname: Xu, Binghe |
| Copyright | Copyright © 2021. Published by Elsevier Ltd. |
| Copyright_xml | – notice: Copyright © 2021. Published by Elsevier Ltd. |
| CorporateAuthor | Panelists of the St Gallen Consensus Conference |
| CorporateAuthor_xml | – name: Panelists of the St Gallen Consensus Conference |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.annonc.2021.06.023 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1569-8041 |
| ExternalDocumentID | 34242744 |
| Genre | Practice Guideline Review |
| GroupedDBID | --- -E4 .2P .86 .I3 .XZ .ZR 08P 0R~ 0U7 1TH 23M 2WC 4.4 482 53G 5GY 5VS 5WA 6J9 70D AAEDW AAGQS AAJKP AAJQQ AAKAS AAKUH AALRI AAMVS AAOGV AAPNW AAUQX AAXUO AAYWO ABEUO ABIXL ABJNI ABKDP ABLJU ABNGD ABNKS ABOCM ABQLI ABSMQ ABZBJ ACGFO ACGFS ACPQN ACPRK ACUKT ACUTO ACVFH ADBBV ADCNI ADEYI ADHKW ADHZD ADOCK ADRTK ADVLN ADYVW ADZCM ADZXQ AEGPL AEGXH AEHUL AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AEUPX AEWNT AFETI AFIYH AFJKZ AFOFC AFPUW AFSHK AGCQF AGINJ AGKEF AGKRT AGQPQ AGSYK AHMBA AHXPO AIAGR AIGII AIJHB AITUG AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS ALUQC AMRAJ APIBT APWMN APXCP AQKUS ASPBG ATTQO AVWKF AXUDD AZFZN BAWUL BAYMD BGNMA BHONS BTRTY BVRKM BZKNY C1A CAG CDBKE CGR CKLRP COF CS3 CUY CVF CZ4 DAKXR DIK DILTD DL5 D~K E3Z EBS ECM EE~ EFKBS EIF EJD EX3 FDB FEDTE GJXCC GX1 H13 H5~ HVGLF HW0 HZ~ I09 IH2 IHE J21 KAQDR KDC KOM LAK M-Z M41 M4Y MBLQV MHKGH N9A NGC NOYVH NPM NTWIH NU0 NVLIB O9- OAWHX ODMLO OJQWA OK1 OVD P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RNI ROL RPX RW1 RZC RZE RZF RZO SDH TCURE TEORI TR2 U2A W8F WOQ WOW X7H YAYTL YFH YKOAZ ZKX ZXP ~91 7X8 |
| ID | FETCH-LOGICAL-c501t-da3b42d5378d9821cfa5459d99edd10ca81b46ffc074d55a596c8ac1beb257152 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 587 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000709095000005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1569-8041 |
| IngestDate | Wed Oct 01 14:46:57 EDT 2025 Mon Jul 21 05:58:38 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Keywords | survivorship neoadjuvant adjuvant genetic testing radiation therapy surgery |
| Language | English |
| License | Copyright © 2021. Published by Elsevier Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c501t-da3b42d5378d9821cfa5459d99edd10ca81b46ffc074d55a596c8ac1beb257152 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Review-3 ObjectType-Feature-4 ObjectType-Instructional Material/Guideline-2 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC9906308 |
| PMID | 34242744 |
| PQID | 2550261081 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2550261081 pubmed_primary_34242744 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-10-01 |
| PublicationDateYYYYMMDD | 2021-10-01 |
| PublicationDate_xml | – month: 10 year: 2021 text: 2021-10-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Annals of oncology |
| PublicationTitleAlternate | Ann Oncol |
| PublicationYear | 2021 |
| SSID | ssj0006929 |
| Score | 2.7356246 |
| SecondaryResourceType | review_article |
| Snippet | The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held virtually, owing to the global COVID-19 pandemic. More than 3300... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1216 |
| SubjectTerms | Breast Neoplasms - diagnosis Breast Neoplasms - epidemiology Breast Neoplasms - therapy COVID-19 Female Humans Neoadjuvant Therapy Pandemics SARS-CoV-2 |
| Title | Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34242744 https://www.proquest.com/docview/2550261081 |
| Volume | 32 |
| WOSCitedRecordID | wos000709095000005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NS8NAEF3Uinjx-6N-MYLXaNJkk6wXkWLrwZaCCr2Fze4GejCtTerBX-TPdGaTWgQFwUtOSUgym533ZmffY-wiiLTBxCYdqVWIBCUVjtCu62gu05BnaepLu1H4Ier34-FQDOqCW1G3Vc7nRDtR67GiGvkVQl-iC5jBbiavDrlG0epqbaGxzBo-Qhlq6YqGC7XwUFiXMqQowiGdnfnWOdvfJXPk1yRi2PKsgicZFv0GMm2y6Wz-9zG32EYNM-G2GhfbbMnkO2ytVy-k77KP9gxR38voHTMX2HwGMtdQ6TqPFFTbspBFA4JasDINQCVbMCSIDCm1spegaMhMr-lseCwvoWuNWeBblRHIEpT8NArozkhTi_rs7V2_etxhnP10X6CPtseeO3dP7XunNm1wFHe90tHST4OW5n4UaxG3PJVJBGlCC2G09lwlEScHYZYpxC6ac8lFqGKpvBQpPo8QTeyzFQyMOWTAQ-NLJDQmVF4gfR1ncerqQCDE8bSJoyY7n8cgwZ-CVjpkbsazIllEockOqkAmk0q9I_EDRCVREBz94epjtk6vWjXvnbBGhlOCOWWr6q0cFdMzO9rw2B_0PgG5aOJ6 |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Customizing+local+and+systemic+therapies+for+women+with+early+breast+cancer%3A+the+St.+Gallen+International+Consensus+Guidelines+for+treatment+of+early+breast+cancer+2021&rft.jtitle=Annals+of+oncology&rft.au=Burstein%2C+H+J&rft.au=Curigliano%2C+G&rft.au=Th%C3%BCrlimann%2C+B&rft.au=Weber%2C+W+P&rft.date=2021-10-01&rft.eissn=1569-8041&rft.volume=32&rft.issue=10&rft.spage=1216&rft_id=info:doi/10.1016%2Fj.annonc.2021.06.023&rft_id=info%3Apmid%2F34242744&rft_id=info%3Apmid%2F34242744&rft.externalDocID=34242744 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1569-8041&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1569-8041&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1569-8041&client=summon |